| __timestamp | Opthea Limited | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3401685 | 31354781 |
| Thursday, January 1, 2015 | 4284228 | 43445817 |
| Friday, January 1, 2016 | 3581295 | 66489820 |
| Sunday, January 1, 2017 | 4838300 | 96886134 |
| Monday, January 1, 2018 | 24891534 | 153793000 |
| Tuesday, January 1, 2019 | 31347891 | 148369000 |
| Wednesday, January 1, 2020 | 17480747 | 151934000 |
| Friday, January 1, 2021 | 34710152 | 198532000 |
| Saturday, January 1, 2022 | 108459978 | 112128000 |
| Sunday, January 1, 2023 | 181563523 | 76192000 |
| Monday, January 1, 2024 | 176326321 |
Data in motion
In the competitive landscape of biotechnology, innovation is the lifeblood of success. Opthea Limited and TG Therapeutics, Inc. are two companies that have consistently invested in research and development (R&D) to drive their growth. From 2014 to 2023, TG Therapeutics led the charge with a peak R&D investment in 2021, spending nearly 200% more than Opthea in 2014. However, Opthea has shown remarkable growth, increasing its R&D expenses by over 5000% from 2014 to 2023, surpassing TG Therapeutics in 2023. This shift highlights Opthea's commitment to innovation, even as TG Therapeutics faced a decline in 2023. The data suggests a dynamic shift in the biotech sector, where Opthea's aggressive investment strategy could position it as a formidable player in the coming years. Missing data for TG Therapeutics in 2024 indicates potential strategic changes or reporting delays.
Analyzing R&D Budgets: Sanofi vs Opthea Limited
Regeneron Pharmaceuticals, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Opthea Limited
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs TG Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BeiGene, Ltd. and TG Therapeutics, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs TG Therapeutics, Inc.
R&D Insights: How Insmed Incorporated and TG Therapeutics, Inc. Allocate Funds
R&D Insights: How Opthea Limited and Alpine Immune Sciences, Inc. Allocate Funds
Opthea Limited vs TG Therapeutics, Inc.: SG&A Expense Trends
R&D Spending Showdown: Opthea Limited vs Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: TG Therapeutics, Inc. vs HUTCHMED (China) Limited
Comparing Innovation Spending: TG Therapeutics, Inc. and Supernus Pharmaceuticals, Inc.